Small Molecules in Oncology

Editors:

ISBN: 978-3-642-01221-1 (Print) 978-3-642-01222-8 (Online)

Table of contents (17 chapters)

  1. Front Matter

    Pages i-xvi

  2. Protein kinase inhibitors

    1. Front Matter

      Pages 1-1

    2. No Access

      Book Chapter

      Pages 3-20

      Imatinib Mesylate

    3. No Access

      Book Chapter

      Pages 21-31

      Erlotinib

    4. No Access

      Book Chapter

      Pages 33-44

      Axitinib (AG-013736)

    5. No Access

      Book Chapter

      Pages 45-59

      Lapatinib

    6. No Access

      Book Chapter

      Pages 61-70

      Sorafenib

    7. No Access

      Book Chapter

      Pages 71-82

      Sunitinib

    8. No Access

      Book Chapter

      Pages 83-102

      Dasatinib

    9. No Access

      Book Chapter

      Pages 103-117

      Nilotinib

    10. No Access

      Book Chapter

      Pages 119-127

      Bosutinib

  3. Epigenetic modifiers

    1. Front Matter

      Pages 130-130

    2. No Access

      Book Chapter

      Pages 131-157

      Decitabine

    3. No Access

      Book Chapter

      Pages 159-170

      5-Azacytidine/Azacitidine

  4. Cell cycle inhibitors

    1. Front Matter

      Pages 172-172

    2. No Access

      Book Chapter

      Pages 173-187

      Bortezomib

    3. No Access

      Book Chapter

      Pages 189-197

      Temsirolimus

    4. No Access

      Book Chapter

      Pages 199-214

      Danusertib (formerly PHA-739358) – A Novel Combined Pan-Aurora Kinases and Third Generation Bcr-Abl Tyrosine Kinase Inhibitor

    5. No Access

      Book Chapter

      Pages 215-218

      BI_2536 - Targeting the Mitotic Kinase Polo-Like Kinase 1 (Plk1)

  5. Other novel agents

    1. Front Matter

      Pages 220-220

    2. No Access

      Book Chapter

      Pages 221-234

      Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy

    3. No Access

      Book Chapter

      Pages 235-238

      GDC-0449 - Targeting the Hedgehog Signaling Pathway